telehealth glp-1 crackdown news FDA takes aim at companies for promoting unofficial weight loss drug dupes New project announcement: HHS‑OIG is

Ethics statement The studies involving humans were approved by Research Ethics Committee, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan

doi: 10.1002/14651858.CD003538.PUB2 247 NortonRLHoffmannPR

This does not establish general repair of damaged human DNA

[Rapid weight loss through GLP-1 receptor agonists as lifestyle phenomenon and implications for plastic esthetic medicine]

& Wang, Z

Soluble fiber and resistant starch are secondary GLP-1 activators that work through a different mechanismthey feed beneficial gut bacteria that produce short-chain fatty acids, which in turn stimulate L-cell secretion